Rhythm Pharmaceuticals Stock News & Updates

[WKN: A2H5A0 | Symbol: RYTM]

Rhythm Pharmaceuticals

Escalating Middle East Conflict Weighs Heavily on Wall Street and DAX – Oil Prices Approach $110 Mark and Fuel Global Interest Rate Fears – Gold Price Experiences Massive Sell-Off with Largest Weekly Loss Since 2020 – Firefly and Intuitive Machines Target Billion-Dollar Revenue in the Growing new Space Sector - NVIDIA Secures AI Mega-Order from Amazon – Biotech Company Rhythm Pharmaceuticals Obtains Lucrative FDA Approval Expansion

03/20/2026 at 11 AM

Bayer AG [DE000BAY0017] ODDO BHF upgrades from "Neutral" to "Outperform" and raises the price target...

02/27/2026 at 01 PM

Nordex [DE000A0D6554] Deutsche Bank reaffirms Buy rating and raises the price target from €34 to...

12/12/2025 at 02 PM

Commercially already on the market: IMCIVREE (Setmelanotid) reduces the "all-or-nothing" risk of...

12/11/2025 at 05 PM

Tech Stocks Plummet – Oracle Fuels AI Doubts The US stock markets , especially the tech-heavy Nasdaq...

10/30/2025 at 06 PM

Currently, our screening includes 23 biopharma stocks that have risen by at least 10% in the last 20...

09/04/2025 at 05 PM

Dear readers, Last week, I introduced five biopharma stocks that have taken off in recent weeks. It...

08/12/2025 at 01 PM

Rhythm Pharmaceuticals is on the verge of the first approval for rare hypothalamic obesity – a billion-dollar...

07/11/2025 at 01 PM

Stock fireworks after study data: Rhythm impresses with strong phase-2 results for an oral obesity...

07/09/2025 at 05 PM

An impressive comeback of technology stocks is boosting global equity markets. Fueled by a strong rise...

07/09/2025 at 04 PM

Aehr Test Systems (AEHR) under pressure: delayed orders and EV market weakness are weighing on the outlook!...

04/09/2025 at 11 AM

• Success with IMCIVREE®: Rhythm achieves breakthrough in previously untreatable form of obesity...